Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 7/20 | 0.50 |
| ▸ | HRH1 | P35367 | 5/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.38 |
| ▸ | DRD3 | P35462 | 2/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2786275 | 0.98 | HTR2A (0.48) | HTR2AHRH1CA1CA2CHRM2 | |
| SCHEMBL14759063 | 0.93 | HTR2A (0.52) | HTR2AHRH1CA1CA2CHRM2 | |
| SCHEMBL31026220 | 0.93 | HTR2A (0.52) | HTR2AHRH1CA1CA2CHRM2 | |
| SCHEMBL17022715 | 0.89 | HTR2A (0.61) | HTR2AHRH1CA1CA2CHRM2 | |
| SCHEMBL5355395 | 0.86 | HTR2A (0.54) | HTR2AHRH1CA1CA2CHRM2 | |
| SCHEMBL29617353 | 0.86 | HTR2A (0.54) | HTR2AHRH1CA1CA2CHRM2 | |
| SCHEMBL7574105 | 0.84 | HTR2A (0.61) | HTR2AHRH1CA1CA2CHRM2 | |
| SCHEMBL27489448 | 0.83 | HTR2A (0.41) | HTR2AACHEBCHE | |
| SCHEMBL17767357 | 0.83 | HTR2A (0.37) | HTR2AHRH1CA1CA2CHRM2 | |
| SCHEMBL5353138 | 0.81 | HTR2A (0.64) | HTR2AHRH1CA1CA2CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006137818-A1 | CATALYST COMPONENTS AND THEIR USE IN THE POLYMERIZATION OF OLEFINS | FINA TECHNOLOGY, INC. (US) | 2006-12-28 | — | — | WO | disclosed |
| US-20050148460-A1 | Catalyst components and their use in the polymerization of olefins | FINA TECHNOLOGY, INC. | 2005-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050148460-A1 | Catalyst components and their use in the polymerization of olefins | NPY5R, SSTR5, FGR | HTR2A 621/4885HRH1 929/4885CA1 4098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.